Global Biosurfactants Market is poised to witness remarkable growth trends from 2023 to 2032 owing to the shifting consumer inclination toward bio-based eco-friendly products across developed markets such as Europe. The transition can be attributed to the increased cognizance of the ill effects of chemical-based products on human health and the rising environmental and health concerns.

Based on estimates by the U.S. Department of Agriculture, the market for organic food products in the EU recorded a 15% uptick and reached USD 52.5 billion in 2020. On the other hand, the per capita organic food consumption in the region, has nearly doubled since the last decade and stood at over USD 106 in 2020, indicating substantial growth potential for the biosurfactants industry.

The bio-based surfactants market is categorized based on product, application, and region.

Regarding the product spectrum, the sorbitan esters segment accounted for over USD 80 million in 2022 and is expected to grow at an appreciable pace from 2023 to 2032. Sorbitan esters are a range of non-ionic surfactants widely used as emulsifying agents in a variety of creams, emulsions, and ointments for cosmetic and pharmaceutical use. Besides, their increasing utilization as dispersants, solubilizers, electrolyte tolerant, and wetting agents will help the segment gain significant momentum over the next ten years.

Additionally, the phospholipids segment value crossed USD 95 million in 2022. The increasing product demand across the medical & healthcare sector owing to its application in several medicinal formulations will boost the market growth.

The lipopeptides from the bioremedian application segment is anticipated to amass more than USD 400 million by 2032. Lipopeptide surfactants boast superior biodegradability, low toxicity, and high stability under several environmental conditions. These attributes have pushed their utilization in the remediation of organic & inorganic pollutants as a potential alternative to chemical surfactants, driving their demand throughout the forecast period.

From the regional perspective, the Asia pacific biosurfactant market from sophorolipids product is primed to accumulate over more than USD 1 billion by 2032. The regional industry is fueled by the availability of raw materials at affordable prices, inexpensive labor, and an environment suitable for biosurfactant industry growth. In addition, the presence of a robust manufacturing sector will open new growth avenues for the regional market.

On the other hand, the Europe biosurfactants market from phospholipids products was worth over USD 25 million in 2022 and is expected to expand exponentially through 2032. The industry growth is aided by increasing R&D investments and rising healthcare expenditure. Additionally, the flourishing pharmaceutical sector and the rapid emergence of biologics and biosimilars will fuel the phospholipids demand across Europe.